Trinralin 10 10 mg Tablets
PDF Leaflet Revision Date: 06 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension.
Dosage (summary)
100-200 mg/day, starting with 10-20 mg 2-4 times daily, max 300 mg/day.
Special Populations
- Slow acetylators
- Elderly
Pregnancy & Breastfeeding
Safety during pregnancy and lactation not established.
Key Drug Interactions
- Other antihypertensives
- Anaesthetics
- Tricyclic antidepressants
Contraindications
- Hypersensitivity to hydralazine
- Tachycardia
Common side effects
- Headache
- Nausea
- Palpitations
- Tachycardia
Counselling Points
- Monitor for hypotension
- Report any unusual symptoms
- Avoid alcohol
Serious warnings
- Risk of lupus-like syndrome
- Caution in coronary artery disease
Important Disclaimer
The Trinralin 10 10 mg Tablets professional information leaflet below is the property of Strides Pharma Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
